NUR1211 Final Test Study Guide |\ |\ |\ |\ |\
questions with answers |\ |\
Benign tumor - CORRECT ANSWERS ✔✔Well-differentiated
|\ |\ |\ |\ |\ |\
neoplasm, non-invasive and non-cancerous
|\ |\ |\
Malignant tumor - CORRECT ANSWERS ✔✔Neoplasm ranging
|\ |\ |\ |\ |\ |\ |\
from well-differentiated to undifferentiated, invasive and
|\ |\ |\ |\ |\ |\
cancerous
TNM staging - CORRECT ANSWERS ✔✔Anatomic extent
|\ |\ |\ |\ |\ |\ |\
determination based on tumor size and invasiveness (T), lymph
|\ |\ |\ |\ |\ |\ |\ |\ |\
node spread (N), and distant organ metastasis (M)
|\ |\ |\ |\ |\ |\ |\
Carcinoma in situ - CORRECT ANSWERS ✔✔Non-invasive cancer
|\ |\ |\ |\ |\ |\ |\ |\
with histologic cancer characteristics except invasion
|\ |\ |\ |\ |\
Biopsy - CORRECT ANSWERS ✔✔Histologic examination of tissue
|\ |\ |\ |\ |\ |\ |\ |\
obtained via needle, incisional, or excisional procedure
|\ |\ |\ |\ |\ |\
Debulking procedure - CORRECT ANSWERS ✔✔Surgical tumor
|\ |\ |\ |\ |\ |\ |\
mass reduction to enhance chemotherapy or radiation therapy
|\ |\ |\ |\ |\ |\ |\ |\
effectiveness
Emesis management - CORRECT ANSWERS ✔✔Prophylactic
|\ |\ |\ |\ |\ |\
antiemetics, antidiarrheal, and antimotility medications, along
|\ |\ |\ |\ |\ |\
with assessing for signs of alkalosis and dehydration
|\ |\ |\ |\ |\ |\ |\
, Chemotherapy extravasation - CORRECT ANSWERS ✔✔Infiltration |\ |\ |\ |\ |\
of drugs into surrounding tissues causing local tissue damage,
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
requiring immediate action to minimize further damage
|\ |\ |\ |\ |\ |\
Neutropenia - CORRECT ANSWERS ✔✔Low neutrophil count
|\ |\ |\ |\ |\ |\ |\
leading to infection, hemorrhage, and overwhelming fatigue
|\ |\ |\ |\ |\ |\
Cancer markers - CORRECT ANSWERS ✔✔Oncofetal antigens
|\ |\ |\ |\ |\ |\ |\
used as tumor markers to monitor therapy effects and tumor
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
recurrence
Tumor Lysis Syndrome - CORRECT ANSWERS ✔✔Early symptoms
|\ |\ |\ |\ |\ |\ |\ |\
include weakness, muscle cramps, diarrhea, nausea, and
|\ |\ |\ |\ |\ |\ |\
vomiting, with hallmark signs of hyperuricemia,
|\ |\ |\ |\ |\ |\
hyperphosphatemia, hyperkalemia, and hypocalcemia |\ |\ |\
Pancytopenia - CORRECT ANSWERS ✔✔Low platelets, RBCs, and
|\ |\ |\ |\ |\ |\ |\ |\
WBCs leading to fatigue, weakness, and anemia
|\ |\ |\ |\ |\ |\
Radioactive implant - CORRECT ANSWERS ✔✔Patient emitting
|\ |\ |\ |\ |\ |\ |\
radioactivity from permanently or temporarily placed implants,
|\ |\ |\ |\ |\ |\ |\
requiring care organization and shielding
|\ |\ |\ |\
Hypercalcemia - CORRECT ANSWERS ✔✔Excess serum calcium |\ |\ |\ |\ |\ |\ |\
levels leading to symptoms and potential life-threatening
|\ |\ |\ |\ |\ |\ |\
complications
questions with answers |\ |\
Benign tumor - CORRECT ANSWERS ✔✔Well-differentiated
|\ |\ |\ |\ |\ |\
neoplasm, non-invasive and non-cancerous
|\ |\ |\
Malignant tumor - CORRECT ANSWERS ✔✔Neoplasm ranging
|\ |\ |\ |\ |\ |\ |\
from well-differentiated to undifferentiated, invasive and
|\ |\ |\ |\ |\ |\
cancerous
TNM staging - CORRECT ANSWERS ✔✔Anatomic extent
|\ |\ |\ |\ |\ |\ |\
determination based on tumor size and invasiveness (T), lymph
|\ |\ |\ |\ |\ |\ |\ |\ |\
node spread (N), and distant organ metastasis (M)
|\ |\ |\ |\ |\ |\ |\
Carcinoma in situ - CORRECT ANSWERS ✔✔Non-invasive cancer
|\ |\ |\ |\ |\ |\ |\ |\
with histologic cancer characteristics except invasion
|\ |\ |\ |\ |\
Biopsy - CORRECT ANSWERS ✔✔Histologic examination of tissue
|\ |\ |\ |\ |\ |\ |\ |\
obtained via needle, incisional, or excisional procedure
|\ |\ |\ |\ |\ |\
Debulking procedure - CORRECT ANSWERS ✔✔Surgical tumor
|\ |\ |\ |\ |\ |\ |\
mass reduction to enhance chemotherapy or radiation therapy
|\ |\ |\ |\ |\ |\ |\ |\
effectiveness
Emesis management - CORRECT ANSWERS ✔✔Prophylactic
|\ |\ |\ |\ |\ |\
antiemetics, antidiarrheal, and antimotility medications, along
|\ |\ |\ |\ |\ |\
with assessing for signs of alkalosis and dehydration
|\ |\ |\ |\ |\ |\ |\
, Chemotherapy extravasation - CORRECT ANSWERS ✔✔Infiltration |\ |\ |\ |\ |\
of drugs into surrounding tissues causing local tissue damage,
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
requiring immediate action to minimize further damage
|\ |\ |\ |\ |\ |\
Neutropenia - CORRECT ANSWERS ✔✔Low neutrophil count
|\ |\ |\ |\ |\ |\ |\
leading to infection, hemorrhage, and overwhelming fatigue
|\ |\ |\ |\ |\ |\
Cancer markers - CORRECT ANSWERS ✔✔Oncofetal antigens
|\ |\ |\ |\ |\ |\ |\
used as tumor markers to monitor therapy effects and tumor
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
recurrence
Tumor Lysis Syndrome - CORRECT ANSWERS ✔✔Early symptoms
|\ |\ |\ |\ |\ |\ |\ |\
include weakness, muscle cramps, diarrhea, nausea, and
|\ |\ |\ |\ |\ |\ |\
vomiting, with hallmark signs of hyperuricemia,
|\ |\ |\ |\ |\ |\
hyperphosphatemia, hyperkalemia, and hypocalcemia |\ |\ |\
Pancytopenia - CORRECT ANSWERS ✔✔Low platelets, RBCs, and
|\ |\ |\ |\ |\ |\ |\ |\
WBCs leading to fatigue, weakness, and anemia
|\ |\ |\ |\ |\ |\
Radioactive implant - CORRECT ANSWERS ✔✔Patient emitting
|\ |\ |\ |\ |\ |\ |\
radioactivity from permanently or temporarily placed implants,
|\ |\ |\ |\ |\ |\ |\
requiring care organization and shielding
|\ |\ |\ |\
Hypercalcemia - CORRECT ANSWERS ✔✔Excess serum calcium |\ |\ |\ |\ |\ |\ |\
levels leading to symptoms and potential life-threatening
|\ |\ |\ |\ |\ |\ |\
complications
